Stay updated on Comparing Crenolanib vs Midostaurin in AML Clinical Trial
Sign up to get notified when there's something new on the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page.

Latest updates to the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the study record itself.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0 from the history.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Contacts/Locations, Study Status, and Study Design sections to the record history; removed Recruiting status and related entries (including Arog Pharmaceuticals, Inc., 2020-05-22, and verification notes).SummaryDifference1%

- Check51 days agoChange DetectedRevision v3.5.0 was added to the history and revision v3.4.3 was removed from the history.SummaryDifference0.1%

- Check65 days agoChange DetectedThe record history now shows Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

- Check72 days agoChange DetectedNew version entries appear in the Record History with updated submission dates; core trial details and statuses remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Comparing Crenolanib vs Midostaurin in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page.